Browse grants
Federal and state grant opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying. Or browse the complete index →
Minor Use Minor Species Development of Drugs (R01)
Due Jan 29, 2027Food and Drug Administration · Up to $250K
An FDA R01 funding safety and effectiveness testing to support approval of drugs for minor uses or minor species (MUMS) in veterinary medicine. Eligibility is limited to entities developing such drugs (or their research partners) that already hold an INAD file and a MUMS designation from FDA/CVM, with a protocol pre-reviewed by FDA, so this requires existing regulatory standing with FDA. Awards reach up to about $250,000. Not a fit unless the applicant is already in the FDA veterinary drug development pipeline.
ResearchersSmall businessNarrow eligibilityReissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)
Due Feb 8, 2028Food and Drug Administration · Up to $600K
This FDA award (up to $600,000) funds natural history studies that generate high-quality data to support medical product development for rare diseases with unmet needs. Eligibility is very broad, covering universities, nonprofits (with or without 501(c)(3) status), small and other for-profit businesses, tribal and local/state governments, and even foreign organizations and their non-U.S. components. No unusual disqualifiers are noted, and the deadline is not imminent.
NonprofitsSmall businessResearchersSchools & universities+3 moreAnimal and Veterinary Innovation Centers (U18)
Due May 12, 2028Food and Drug Administration · Up to $1.3M
Open to public and private higher-education institutions, including HBCUs, tribal colleges, and other minority-serving institutions. This FDA U18 forms long-term academic partnerships to research avian influenza and emerging zoonotic threats, intentional genomic alterations in animals, and products for minor and veterinary species. Awards up to about $1,250,000.
Schools & universitiesResearchersGovernment / tribalLarge awardReissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)
Due May 16, 2028Food and Drug Administration · Up to $900K
Open to nearly any organization — universities, nonprofits (with or without 501(c)(3)), for-profits and small businesses, state/local/tribal governments, and foreign organizations. This FDA R01 funds clinical trials of orphan products evaluating safety and efficacy to address unmet needs in rare diseases. Awards up to about $900,000; clinical trials are required.
ResearchersNonprofitsSmall businessGovernment / tribal+3 more